{"filing":{"accession_number":"0001493152-26-029085","cik":"0001583771","ticker":"CTRVP","company_name":"Hepion Pharmaceuticals, Inc.","form":"8-K","filing_date":"2026-06-17","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226029085/form8-k.htm"},"events":[{"id":11560,"run_id":10150,"accession_number":"0001493152-26-029085","anchor_item_number":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses Item 5.07 results from Hepion Pharmaceuticals' 2026 Annual Meeting of Stockholders held on June 17, 2026, including voting outcomes on three proposals: election of five directors (Gary Stetz, Vincent LoPriore, Michael Purcell, Sireesh Appajosyula, and Chase LoPriore), ratification of Grassi \u0026 Co. as independent auditors, and approval of an amendment to the 2023 Omnibus Equity Incentive Plan to increase authorized shares to 8,000,000. These shareholder votes are material to investors as they determine board composition and equity plan capacity.","company_name":"Hepion Pharmaceuticals, Inc.","ticker":"CTRVP","filing_date":"2026-06-17","submitted_at":null,"items":null}],"classifications":[{"id":8176,"accession_number":"0001493152-26-029085","item_number":null,"item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses Item 5.07 results from Hepion Pharmaceuticals' 2026 Annual Meeting of Stockholders held on June 17, 2026, including voting outcomes on three proposals: election of five directors (Gary Stetz, Vincent LoPriore, Michael Purcell, Sireesh Appajosyula, and Chase LoPriore), ratification of Grassi \u0026 Co. as independent auditors, and approval of an amendment to the 2023 Omnibus Equity Incentive Plan to increase authorized shares to 8,000,000. These shareholder votes are material to investors as they determine board composition and equity plan capacity.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:17:05.760483+00:00","company_name":"Hepion Pharmaceuticals, Inc.","ticker":"CTRVP","filing_date":"2026-06-17"}]}